What is presbyopia?
In a person’s early 40s, a normal part of aging is that eyes gradually lose the ability to see things clearly up close, such as reading materials or cellphone screens1
1.7 billion people are defined as presbyopes globally2
In Europe, over 64 million people suffer from presbyopia, which is 84% of 45–60-year-olds3
EVO Viva™ Implantable Collamer® Lenses (ICLs) are made from the same high-quality materials found in STAAR ICLs that treat myopia
The unique benefits of EVO Viva ICLs include:
- Improved vision at all distances4
- Harmonizes with your natural eye: additive, removable, upgradable
- A quick procedure
- UV protection
- High patient satisfaction4
References:
1. Boyd, K. What Is Presbyopia? American Academy of Ophthalmology. 2020. Available at:
https://www.aao.org/eye-health/diseases/what-is-presbyopia
2. Fricke TR, Tahhan N, Resnikoff S, et al. Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia. 2018;125(10):1492-1499.
3. Market Scope, LLC. STAAR Surgical Global Model 2018 to 2024. 2020.
4. EVO Viva Directions For Use. STAAR Surgical.
Important Safety Information for EVO Viva ICL
Implantation of the EVO Viva ICL is a surgical procedure, and as such, carries potentially serious risks. The EVO Viva ICL is designed for the correction/reduction of up to -20 diopters (D) of nearsightedness with or without presbyopia for patients who are 21 to 60 years of age and for patients 21 years of age or older who have been treated with an intraocular lens. Before considering EVO Viva ICL surgery you should have a complete eye examination and talk with your eye care professional about the procedure, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.
